CIK 0001689548 · Large accelerated filer
Praxis Precision Medicines, Inc.
Sign in to watch- Ticker
- PRAX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-300-8460
- Business address
- 99 HIGH STREET, 30TH FLOOR, BOSTON, MA, 02110
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- UPLOAD Other SEC-generated Letter
- DRS Other Draft Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Grant or award Chief Commercial Officer acquired 16,800 shares (grant or award)
- 4 Grant or award General Counsel and Secretary acquired 12,400 shares (grant or award)
- 4 Grant or award Principal Accounting Officer acquired 8,200 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 52,800 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 24,512 shares (grant or award)
- SC 13G Stake Amended Statement of Ownership
- 4/A Open-market buy Director bought 250,000 shares at $19.00 ($4,750,000)
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
Page 23 of 26 · 514 filings